Managing Alprazolam (Xanax) Withdrawal with Lorazepam (Ativan)
For adult patients experiencing alprazolam withdrawal, convert to an equivalent dose of lorazepam and implement a gradual taper reducing the dose by 10-20% every 1-2 weeks, extending over several months to minimize withdrawal symptoms and prevent life-threatening complications. 1
Conversion Protocol
Step 1: Calculate Equivalent Lorazepam Dose
- Alprazolam and lorazepam have approximately 1:1 potency equivalence in clinical practice, though some sources suggest lorazepam may be slightly less potent 2
- Calculate the patient's total daily alprazolam dose
- Convert to an equivalent lorazepam dose (typically 1 mg alprazolam = 1 mg lorazepam)
- Divide into 3-4 doses per day initially (every 6-8 hours) 3
Step 2: Initiate Cross-Taper
- Do NOT abruptly discontinue alprazolam, as this can precipitate life-threatening withdrawal including seizures, delirium tremens, and death 1
- Begin lorazepam at the calculated equivalent dose while maintaining alprazolam
- Over 2-3 days, gradually reduce alprazolam by 25-50% while maintaining full lorazepam dose 4
- Complete transition to lorazepam by day 3-4
Tapering Schedule
General Tapering Principles
The taper should extend over months, not weeks, with dose reductions of 10-20% every 1-2 weeks 3, 5. The FDA label for alprazolam specifically recommends reducing by no more than 0.5 mg every 3 days, but clinical evidence supports even slower tapers 1.
Specific Taper Protocol
- Week 1-2: Maintain full converted lorazepam dose to stabilize
- Subsequent weeks: Reduce by 10-20% of the current dose every 1-2 weeks 3
- Alternative approach: Gradually extend dosing intervals from every 6h → every 8h → every 12h → every 24h → every other day before discontinuation 3
- Final doses: Taper to very low doses (0.25-0.5 mg lorazepam) before complete cessation 6
Duration Considerations
- The required tapering time is proportional to the duration of benzodiazepine use 3
- Patients on high doses (>4 mg alprazolam equivalent) or long-term use (>6 months) require slower tapers extending 3-6 months or longer 6
- A slower taper schedule is associated with reduced withdrawal symptoms compared to rapid tapers 1
Critical Safety Considerations
High-Risk Situations Requiring Hospitalization
- History of withdrawal seizures or delirium tremens 4
- Concurrent alcohol use disorder 4
- Serious medical or psychiatric comorbidities 4
- Doses >4 mg daily alprazolam equivalent 1
- Previous failed outpatient taper attempts 4
Monitoring Withdrawal Symptoms
Signs of benzodiazepine withdrawal can be delayed and include 3:
- Anxiety, agitation, insomnia
- Tremor, sweating, tachycardia
- Perceptual disturbances
- Seizures (medical emergency)
- Delirium (medical emergency)
Managing Withdrawal Reactions
- If withdrawal symptoms emerge, pause the taper or increase back to the previous dose level 1
- Subsequently decrease more slowly (reduce taper increments to 5-10% every 2-4 weeks) 6
- Some patients may prove resistant to all discontinuation regimens and require indefinite maintenance 1
Adjunctive Interventions
Pharmacological Support
- Carbamazepine can be used as an alternative or adjunct for seizure prevention, though it also requires tapering 7, 5
- Avoid other CNS depressants during taper (opioids, alcohol, sedatives) due to increased overdose risk 5
- Thiamine supplementation (100-300 mg/day) if concurrent alcohol use 4
Psychosocial Interventions
Cognitive-behavioral therapy (CBT) significantly increases tapering success rates and should be offered to all patients 5, 6. Additional supportive measures include 6:
- Patient education about withdrawal risks and benefits of tapering
- Shared decision-making throughout the process
- Anxiety management techniques
- Sleep hygiene optimization
- Regular follow-up and monitoring
Special Populations
Geriatric Patients
- Start with lower lorazepam doses (0.25 mg 2-3 times daily) 1
- Use even slower taper schedules (reduce by 5-10% every 2-4 weeks) 7
- Monitor closely for cognitive impairment and falls 7
Hepatic Impairment
- Start with reduced doses (0.25 mg 2-3 times daily) 1
- Lorazepam is preferred over alprazolam due to simpler metabolism 4
- Monitor for accumulation and adjust taper accordingly
Common Pitfalls to Avoid
- Tapering too rapidly: The most common cause of taper failure is reducing doses too quickly 6, 8
- Stopping at therapeutic minimum doses: Taper should continue to very low doses (0.25 mg or less) before discontinuation 6, 8
- Abrupt discontinuation: Never stop benzodiazepines abruptly in dependent patients 1, 6
- Inadequate monitoring: Withdrawal symptoms can be delayed; close follow-up is essential 3
- Mistaking withdrawal for relapse: Anxiety during taper may represent withdrawal rather than return of underlying disorder 6, 9